CA
ELV icon

Calton & Associates’s Elevance Health ELV Stock Holding History

Calton & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-532
Closed -$204K – 410
2021
Q2 		$204K Buy
+532
New +$203K 0.04% 385
2018
Q1 		– Sell
-400
Closed -$100K – 590
2017
Q4 		$100K Buy
+400
New +$85.2K 0.03% 490

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Calton & Associates's ELV Position: Q3 2021 in Review

Calton & Associates sold out of Elevance Health (ELV) in Q3 2021, closing a stake of 532 shares — an estimated $204K sold.

Calton & Associates first reported a position in ELV in Q4 2017 and held it in 2 quarters. The position peaked at $204K in Q2 2021. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • Calton & Associates reported no remaining Elevance Health position as of Q3 2021 after selling out during the quarter.
  • Calton & Associates sold 532 Elevance Health shares in Q3 2021, an estimated $204K.
  • Calton & Associates first reported a position in Elevance Health in Q4 2017 and held it in 2 quarters.
  • Calton & Associates's Elevance Health position peaked at $204K in Q2 2021.
  • 1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Calton & Associates's 13F filing for Q3 2021, filed 5 Nov 2021.